Extracorporeal Membrane Oxygenation Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Modality, Application, and Age Group

List of Tables

The extracorporeal membrane oxygenation market is projected to reach US$ 677.64 million by 2028 from US$ 546.73 million in 2021; it is estimated to grow at a CAGR of 3.1% during 2022-2028.

The report highlights the key factors driving the market and prominent players with their developments. The growth of the extracorporeal membrane oxygenation market is primarily attributed to the rising prevalence of cardiovascular diseases and respiratory failures and the growing adoption of extracorporeal membrane oxygenation in lung transplantation procedures. However, complications associated with extracorporeal membrane oxygenation hinder the growth of the market.

Rising Prevalence of Cardiovascular Diseases and Respiratory Failures Drives extracorporeal membrane oxygenation Market Growth

Extracorporeal membrane oxygenation (extracorporeal membrane oxygenation) is a heart-lungs bypass machine. extracorporeal membrane oxygenation equipment is used in the treatment of cardiovascular diseases and respiratory failures. Millions of deaths due to cardiovascular diseases (CVDs) are recorded every year across the world. CVDs majorly cause mortality and morbidity in Europe, accounting for 45% of deaths in the region and 37% in the European Union (EU). As per the study 'Global Burden of Disease Study 2019,' CVDs were among the leading causes of death in Asia in 2019, causing 10.8 million fatalities (35% of the total fatalities). According to the 2022 Heart Disease & Stroke Statistical Update Fact Sheet, Global Burden of Disease, an estimated 119.1 million patients died of CVDs across the world in 2020. It also stated that the global prevalence of stroke and ischemic stroke in 2020 was 89.1 million and 68.2 million, respectively. High instances of CVDs are observed in North America. As per the National Center for Chronic Disease Prevention and Health Promotion, Division for Heart Disease and Stroke Prevention, ~697,000 people succumbed to heart disease in the US. According to the American Heart Association, over 130 million people in the US (45.1% of total population) are likely to get affected by some form of cardiovascular disease by 2035. Further, according to the National Library of Medicine, in 2022, about 400,000 coronary artery bypass grafting (CABG) surgeries are performed every year.

Chronic obstructive pulmonary disease (COPD) causes obstruction in the airflow from the lungs, which can lead to respiratory failure. It is one of the life-threatening illnesses that cause millions of deaths across the world. According to World Health Organization (WHO), COPD was the third leading cause of death, which caused 3.23 million deaths across the globe in 2019. About 90% of COPD deaths occur in low- and middle-income countries. According to the Centers for Disease Control and Prevention (CDC), in 2020, COPD was the sixth leading cause of death in the US. Therefore, the growing prevalence of cardiovascular diseases and respiratory failures drives the growth of the extracorporeal membrane oxygenation market.

The global extracorporeal membrane oxygenation market, based on modality, is segmented into venoarterial extracorporeal membrane oxygenation, venovenous extracorporeal membrane oxygenation, and arteriovenous extracorporeal membrane oxygenation. The venoarterial extracorporeal membrane oxygenation segment held the largest share of the market in 2021 and is anticipated to register a CAGR of 3.1% in the market during the forecast period. Venoarterial (VA) extracorporeal membrane oxygenation supports the patient's heart and lungs by pushing the blood through the circuit without getting through the patient's heart. This type of extracorporeal membrane oxygenation takes blood out of a large vein and back it into a large artery, allowing oxygen-rich blood to circulate through the body even if the heart is too weak to pump. Veno-arterial extracorporeal membrane oxygenation (VA-extracorporeal membrane oxygenation) has been widely applied over the last decade. It is an effective and valuable therapeutic option in refractory cardiogenic shock of various etiologies. It showed promising results in the specific setting of in-hospital cardiac arrest, and survival rates with good neurological outcomes are reported between 20% and 40%.

Based on application, the global extracorporeal membrane oxygenation market is bifurcated into respiratory and cardiology. The respiratory segment held a larger share of the market in 2021 as extracorporeal membrane oxygenation is used for patients recovering from lung failure. Acute respiratory distress syndrome (ARDS), Blockage in a pulmonary artery in the lungs (pulmonary embolism), and COVID-19 are a few lung diseases where extracorporeal membrane oxygenation is used. extracorporeal membrane oxygenation can support patients body in total absence of lung function. However, the cardiology segment is anticipated to register a CAGR of 3. 6% in the market during the forecast period. extracorporeal membrane oxygenation is also used to support people affected by heart disease that cannot be cured while they wait for an organ transplant. It is used in the treatment of heart attack (acute myocardial infarction), heart muscle disease (decompensated cardiomyopathy), and heart failure. As per the WHO, in 2019, due to CVDs ~17.9 million deaths were recorded accounting for 32% of all global deaths. Increasing prevalence of cardiovascular diseases is likely to increase the demand for extracorporeal membrane oxygenation machines in the coming years.

Food and Drug Administration, Ministry of Statistics and Program Implementation, National Institute of Statistics and Geography, and National Medical Products Administration are a few of the major primary and secondary sources referred to while preparing the report on the extracorporeal membrane oxygenation market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the extracorporeal membrane oxygenation market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global extracorporeal membrane oxygenation market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Product Code: TIPHE100001219

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Global Extracorporeal Membrane Oxygenation Market - By Modality
- 1.3.2 Global Extracorporeal Membrane Oxygenation Market - By Application
- 1.3.3 Global Extracorporeal Membrane Oxygenation Market - By Age Group
- 1.3.4 Global Extracorporeal Membrane Oxygenation Market - By Geography

2. Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Extracorporeal Membrane Oxygenation Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
- 4.2.2 Europe PEST Analysis
- 4.2.3 Asia Pacific PEST Analysis
- 4.2.4 Middle East & Africa PEST Analysis
- 4.2.5 South & Central America PEST Analysis
4.3 Experts Opinion

5. Extracorporeal Membrane Oxygenation Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rising Prevalence of Cardiovascular Diseases and Respiratory Failures
- 5.1.2 Growing Adoption of Extracorporeal Membrane Oxygenation in Lung Transplantation Procedures
5.2 Market Restraints
- 5.2.1 Complications Associated with Extracorporeal Membrane Oxygenation
5.3 Market Opportunities
- 5.3.1 Increasing Survival Rates with Extracorporeal Membrane Oxygenation
5.4 Future Trends
- 5.4.1 Surging Product Developments and Approvals
5.5 Impact Analysis

6. Extracorporeal Membrane Oxygenation Market - Global Analysis

6.1 Global Extracorporeal Membrane Oxygenation Market Revenue Forecast & Analysis
- 6.1.1 Global Extracorporeal Membrane Oxygenation Market Revenue Forecast & Analysis
6.2 Market Positioning Analysis of Key Players in Extracorporeal Membrane Oxygenation Market

7. Extracorporeal Membrane Oxygenation Market Analysis and Forecast To 2028 - By Modality

7.1 Overview
7.2 Global Extracorporeal Membrane Oxygenation Market Share by Modality 2021 & 2028 (%)
7.3 Venoarterial Extracorporeal Membrane Oxygenation
- 7.3.1 Overview
- 7.3.2 Venoarterial Extracorporeal Membrane Oxygenation: Extracorporeal Membrane Oxygenation Market Revenue and Forecast to 2028 (US$ Million)
7.4 Venovenous Extracorporeal Membrane Oxygenation
- 7.4.1 Overview
- 7.4.2 Venovenous Extracorporeal Membrane Oxygenation: Extracorporeal Membrane Oxygenation Market Revenue and Forecast to 2028 (US$ Million)
7.5 Arteriovenous Extracorporeal Membrane Oxygenation
- 7.5.1 Overview
- 7.5.2 Arteriovenous Extracorporeal Membrane Oxygenation: Extracorporeal Membrane Oxygenation Market Revenue and Forecast to 2028 (US$ Million)

8. Extracorporeal Membrane Oxygenation Market Analysis and Forecasts To 2028 - By Application

8.1 Overview
8.2 Global Extracorporeal Membrane Oxygenation Market, By Application 2021 & 2028 (%)
8.3 Cardiology
- 8.3.1 Overview
- 8.3.2 Cardiology Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Respiratory
- 8.4.1 Overview
- 8.4.2 Respiratory Market Revenue and Forecast to 2028 (US$ Mn)

9. Extracorporeal Membrane Oxygenation Market Analysis and Forecasts To 2028 - By Age Group

9.1 Overview
9.2 Global Extracorporeal Membrane Oxygenation Market, By Age Group 2021 & 2028 (%)
9.3 Neonates
- 9.3.1 Overview
- 9.3.2 Neonates Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Pediatrics
- 9.4.1 Overview
- 9.4.2 Pediatrics Market Revenue and Forecast to 2028 (US$ Mn)
9.5 Adults
- 9.5.1 Overview
- 9.5.2 Adults Market Revenue and Forecast to 2028 (US$ Mn)

10. Extracorporeal Membrane Oxygenation Market Revenue and Forecasts to 2028 - Geographical Analysis

10.1 North America: Extracorporeal Membrane Oxygenation Market
- 10.1.1 Overview
- 10.1.2 North America: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.3 North America: Extracorporeal Membrane Oxygenation Market, by Modality, 2020-2028 (US$ Million)
- 10.1.4 North America: Extracorporeal Membrane Oxygenation Market, by Application, 2020-2028 (US$ Million)
- 10.1.5 North America: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020-2028 (US$ Million)
- 10.1.6 North America: Extracorporeal Membrane Oxygenation Market, by Country, 2021 & 2028 (%)
  - 10.1.6.1 US: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.6.1.1 Overview
    - 10.1.6.1.2 US: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.6.1.3 US: Extracorporeal Membrane Oxygenation Market, by Modality, 2020-2028 (US$ Million)
    - 10.1.6.1.4 US: Extracorporeal Membrane Oxygenation Market, by Application, 2020-2028 (US$ Million)
    - 10.1.6.1.5 US: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020-2028 (US$ Million)
  - 10.1.6.2 Canada: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.6.2.1 Overview
    - 10.1.6.2.2 Canada: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.6.2.3 Canada: Extracorporeal Membrane Oxygenation Market, by Modality, 2020-2028 (US$ Million)
    - 10.1.6.2.4 Canada: Extracorporeal Membrane Oxygenation Market, by Application, 2020-2028 (US$ Million)
    - 10.1.6.2.5 Canada: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020-2028 (US$ Million)
  - 10.1.6.3 Mexico: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.6.3.1 Overview
    - 10.1.6.3.2 Mexico: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.6.3.3 Mexico: Extracorporeal Membrane Oxygenation Market, by Modality, 2020-2028 (US$ Million)
    - 10.1.6.3.4 Mexico: Extracorporeal Membrane Oxygenation Market, by Application, 2020-2028 (US$ Million)
    - 10.1.6.3.5 Mexico: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020-2028 (US$ Million)
10.2 Europe: Extracorporeal Membrane Oxygenation Market
- 10.2.1 Overview
- 10.2.2 Europe: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
- 10.2.3 Europe: Extracorporeal Membrane Oxygenation Market, By Modality, 2019-2028 (US$ Million)
- 10.2.4 Europe: Extracorporeal Membrane Oxygenation Market, by Application, 2019-2028 (US$ Million)
- 10.2.5 Europe: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)
- 10.2.6 Europe: Extracorporeal Membrane Oxygenation Market, by Country, 2021 & 2028 (%)
  - 10.2.6.1 Germany: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.1.1 Overview
    - 10.2.6.1.2 Germany: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.1.3 Germany: Extracorporeal Membrane Oxygenation Market, By Modality, 2019-2028 (US$ Million)
    - 10.2.6.1.4 Germany: Extracorporeal Membrane Oxygenation Market, by Application, 2019-2028 (US$ Million)
    - 10.2.6.1.5 Germany: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)
  - 10.2.6.2 UK: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.2.1 Overview
    - 10.2.6.2.2 UK: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.2.3 UK: Extracorporeal Membrane Oxygenation Market, By Modality, 2019-2028 (US$ Million)
    - 10.2.6.2.4 UK: Extracorporeal Membrane Oxygenation Market, by Application, 2019-2028 (US$ Million)
    - 10.2.6.2.5 UK: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)
  - 10.2.6.3 France: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.3.1 Overview
    - 10.2.6.3.2 France: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.3.3 France: Extracorporeal Membrane Oxygenation Market, By Modality, 2019-2028 (US$ Million)
    - 10.2.6.3.4 France: Extracorporeal Membrane Oxygenation Market, by Application, 2019-2028 (US$ Million)
    - 10.2.6.3.5 France: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)
  - 10.2.6.4 Italy: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.4.1 Overview
    - 10.2.6.4.2 Italy: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.4.3 Italy: Extracorporeal Membrane Oxygenation Market, By Modality, 2019-2028 (US$ Million)
    - 10.2.6.4.4 Italy: Extracorporeal Membrane Oxygenation Market, by Application, 2019-2028 (US$ Million)
    - 10.2.6.4.5 Italy: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)
  - 10.2.6.5 Spain: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.5.1 Overview
    - 10.2.6.5.2 Spain: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.5.3 Spain: Extracorporeal Membrane Oxygenation Market, By Modality, 2019-2028 (US$ Million)
    - 10.2.6.5.4 Spain: Extracorporeal Membrane Oxygenation Market, by Application, 2019-2028 (US$ Million)
    - 10.2.6.5.5 Spain: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)
  - 10.2.6.6 Rest of Europe: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.6.1 Overview
    - 10.2.6.6.2 Rest of Europe: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.6.3 Rest of Europe: Extracorporeal Membrane Oxygenation Market, By Modality, 2019-2028 (US$ Million)
    - 10.2.6.6.4 Rest of Europe: Extracorporeal Membrane Oxygenation Market, by Application, 2019-2028 (US$ Million)
    - 10.2.6.6.5 Rest of Europe: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)
10.3 Asia Pacific: Extracorporeal Membrane Oxygenation Market
- 10.3.1 Overview
- 10.3.2 Asia Pacific: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
- 10.3.3 Asia Pacific: Extracorporeal Membrane Oxygenation Market, by Modality, 2020-2028 (US$ Million)
- 10.3.4 Asia Pacific: Extracorporeal Membrane Oxygenation Market, by Application, 2020-2028 (US$ Million)
- 10.3.5 Asia Pacific: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020-2028 (US$ Million)
- 10.3.6 Asia Pacific: Extracorporeal Membrane Oxygenation Market, by Country, 2021 & 2028 (%)
  - 10.3.6.1 China: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.1.1 Overview
    - 10.3.6.1.2 China: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.1.3 China: Extracorporeal Membrane Oxygenation Market, by Modality, 2020-2028 (US$ Million)
    - 10.3.6.1.4 China: Extracorporeal Membrane Oxygenation Market, by Application, 2020-2028 (US$ Million)
    - 10.3.6.1.5 China: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020-2028 (US$ Million)
  - 10.3.6.2 Japan: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.2.1 Overview
    - 10.3.6.2.2 Japan: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.2.3 Japan: Extracorporeal Membrane Oxygenation Market, by Modality, 2020-2028 (US$ Million)
    - 10.3.6.2.4 Japan: Extracorporeal Membrane Oxygenation Market, by Application, 2020-2028 (US$ Million)
    - 10.3.6.2.5 Japan: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020-2028 (US$ Million)
  - 10.3.6.3 India: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.3.1 Overview
    - 10.3.6.3.2 India: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.3.3 India: Extracorporeal Membrane Oxygenation Market, by Modality, 2020-2028 (US$ Million)
    - 10.3.6.3.4 India: Extracorporeal Membrane Oxygenation Market, by Application, 2020-2028 (US$ Million)
    - 10.3.6.3.5 India: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020-2028 (US$ Million)
  - 10.3.6.4 South Korea: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.4.1 Overview
    - 10.3.6.4.2 South Korea: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.4.3 South Korea: Extracorporeal Membrane Oxygenation Market, by Modality, 2020-2028 (US$ Million)
    - 10.3.6.4.4 South Korea: Extracorporeal Membrane Oxygenation Market, by Application, 2020-2028 (US$ Million)
    - 10.3.6.4.5 South Korea: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020-2028 (US$ Million)
  - 10.3.6.5 Australia: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.5.1 Overview
    - 10.3.6.5.2 Australia: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.5.3 Australia: Extracorporeal Membrane Oxygenation Market, by Modality, 2020-2028 (US$ Million)
    - 10.3.6.5.4 Australia: Extracorporeal Membrane Oxygenation Market, by Application, 2020-2028 (US$ Million)
    - 10.3.6.5.5 Australia: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020-2028 (US$ Million)
  - 10.3.6.6 Rest of Asia Pacific: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.6.1 Overview
    - 10.3.6.6.2 Rest of Asia Pacific: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.6.3 Rest of Asia Pacific: Extracorporeal Membrane Oxygenation Market, by Modality, 2020-2028 (US$ Million)
    - 10.3.6.6.4 Rest of Asia Pacific: Extracorporeal Membrane Oxygenation Market, by Application, 2020-2028 (US$ Million)
    - 10.3.6.6.5 Rest of Asia Pacific: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020-2028 (US$ Million)
10.4 South & Central America Extracorporeal Membrane Oxygenation Market
- 10.4.1 Overview
- 10.4.2 South & Central America: Extracorporeal Membrane Oxygenation - Revenue and Forecast to 2028 (US$ Million)
- 10.4.3 South & Central America: Extracorporeal Membrane Oxygenation, by Modality, 2019-2028 (US$ Million)
- 10.4.4 South & Central America: Extracorporeal Membrane Oxygenation, by Application, 2019-2028 (US$ Million)
- 10.4.5 South & Central America: Extracorporeal Membrane Oxygenation, by Age Group, 2019-2028 (US$ Million)
- 10.4.6 South & Central America: Extracorporeal Membrane Oxygenation, by Country, 2021 & 2028 (%)
  - 10.4.6.1 Brazil: Extracorporeal Membrane Oxygenation - Revenue and Forecast to 2028 (US$ Million)
    - 10.4.6.1.1 Brazil: Extracorporeal Membrane Oxygenation - Revenue and Forecast to 2028 (US$ Million)
    - 10.4.6.1.2 Brazil: Extracorporeal Membrane Oxygenation, by Modality, 2019-2028 (US$ Million)
    - 10.4.6.1.3 Brazil: Extracorporeal Membrane Oxygenation, by Application, 2019-2028 (US$ Million)
    - 10.4.6.1.4 Brazil: Extracorporeal Membrane Oxygenation, by Age Group, 2019-2028 (US$ Million)
  - 10.4.6.2 Argentina: Extracorporeal Membrane Oxygenation - Revenue and Forecast to 2028 (US$ Million)
    - 10.4.6.2.1 Argentina: Extracorporeal Membrane Oxygenation - Revenue and Forecast to 2028 (US$ Million)
    - 10.4.6.2.2 Argentina: Extracorporeal Membrane Oxygenation, by Modality, 2019-2028 (US$ Million)
    - 10.4.6.2.3 Argentina: Extracorporeal Membrane Oxygenation, by Application, 2019-2028 (US$ Million)
    - 10.4.6.2.4 Argentina: Extracorporeal Membrane Oxygenation, by Age Group, 2019-2028 (US$ Million)
  - 10.4.6.3 Rest of South & Central America: Extracorporeal Membrane Oxygenation - Revenue and Forecast to 2028 (US$ Million)
    - 10.4.6.3.1 Rest of South & Central America: Extracorporeal Membrane Oxygenation - Revenue and Forecast to 2028 (US$ Million)
    - 10.4.6.3.2 Rest of South & Central America: Extracorporeal Membrane Oxygenation, by Modality, 2019-2028 (US$ Million)
    - 10.4.6.3.3 Rest of South & Central America: Extracorporeal Membrane Oxygenation, by Application, 2019-2028 (US$ Million)
    - 10.4.6.3.4 Rest of South & Central America: Extracorporeal Membrane Oxygenation, by Age Group, 2019-2028 (US$ Million)
10.5 Middle East & Africa: Extracorporeal Membrane Oxygenation Market
- 10.5.1 Middle East & Africa: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)
- 10.5.2 Middle East & Africa: Extracorporeal Membrane Oxygenation Market, by Modality, 2019-2028 (US$ Million)
- 10.5.3 Middle East & Africa: Extracorporeal Membrane Oxygenation Market, by Application, 2019-2028 (US$ Million)
- 10.5.4 Middle East & Africa: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)
- 10.5.5 Middle East & Africa: Extracorporeal Membrane Oxygenation Market, by Country, 2021& 2028 (%)
  - 10.5.5.1 South Africa: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)
    - 10.5.5.1.1 Overview
    - 10.5.5.1.2 South Africa: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)
    - 10.5.5.1.3 South Africa: Extracorporeal Membrane Oxygenation Market, by Modality, 2019-2028 (US$ Million)
    - 10.5.5.1.4 South Africa: Extracorporeal Membrane Oxygenation Market, by Application, 2019-2028 (US$ Million)
    - 10.5.5.1.5 South Africa: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)
  - 10.5.5.2 Saudi Arabia: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)
    - 10.5.5.2.1 Overview
    - 10.5.5.2.2 Saudi Arabia: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)
    - 10.5.5.2.3 Saudi Arabia: Extracorporeal Membrane Oxygenation Market, by Modality, 2019-2028 (US$ Million)
    - 10.5.5.2.4 Saudi Arabia: Extracorporeal Membrane Oxygenation Market, by Application, 2019-2028 (US$ Million)
    - 10.5.5.2.5 Saudi Arabia: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)
  - 10.5.5.3 UAE: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)
    - 10.5.5.3.1 Overview
    - 10.5.5.3.2 UAE: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)
    - 10.5.5.3.3 UAE: Extracorporeal Membrane Oxygenation Market, by Modality, 2019-2028 (US$ Million)
    - 10.5.5.3.4 UAE: Extracorporeal Membrane Oxygenation Market, by Application, 2019-2028 (US$ Million)
    - 10.5.5.3.5 UAE: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)
  - 10.5.5.4 Rest of Middle East & Africa: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)
    - 10.5.5.4.1 Overview
    - 10.5.5.4.2 Rest of Middle East & Africa: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)
    - 10.5.5.4.3 Rest of Middle East & Africa: Extracorporeal Membrane Oxygenation Market, by Modality, 2019-2028 (US$ Million)
    - 10.5.5.4.4 Rest of Middle East & Africa: Extracorporeal Membrane Oxygenation Market, by Application, 2019-2028 (US$ Million)
    - 10.5.5.4.5 Rest of Middle East & Africa: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)

11. Impact Of COVID-19 Pandemic on Extracorporeal Membrane Oxygenation Market

11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 South & Central America: Impact Assessment of COVID-19 Pandemic
11.5 Middle East & Africa: Impact Assessment of COVID-19 Pandemic

12. Extracorporeal Membrane Oxygenation Market-Industry Landscape

12.1 Overview
12.2 Growth Strategies in the Extracorporeal Membrane Oxygenation Market
12.3 Inorganic Growth Strategies
- 12.3.1 Overview
12.4 Organic Growth Strategies
- 12.4.1 Overview

13. Company Profiles

13.1 Terumo Group
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Medtronic Plc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 MicroPort Scientific Corporation
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 LivaNova Plc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Nipro Medical Corporation
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Eurosets S.R.L.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Getinge AB
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Braile Biomedica
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Fresenius Medical Care AG & Co KGaA
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 ABIOMED Inc
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners
14.2 Glossary of Terms